Security Snapshot

ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) Institutional Ownership

CUSIP: 00166B105

13F Institutional Holders and Ownership History from Q3 2020 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

42

Shares (Excl. Options)

21.97MFull value: 21,966,797 · shares · 30 Sep 2026

Price

$1.39

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-2,991,167
Value change
-$6,847,055
Number of holders
42
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
129,403,824
SEC-reported price per share
$1.39
Insider filing price
$1.39
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share is tracked under CUSIP 00166B105.
  • 42 institutions reported positions in Q3 2026.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 93 to 42 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $217.87MFull value: $217,870,738 · USD · 30 Jun 2026
    to
    $30.53MFull value: $30,525,839 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 42 institutions filings for Q3 2026.

Open SEC evidence

Security key

00166B105

13F reference period

Q3 2026

13F holders

42

13D/G owners

10

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
10
Security
ALXO
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $16,265,211 13,117,106 RA Capital Management, L.P. 02 Feb 2026
venBio Global Strategic Fund, L.P. 10% -0.1% $17,961,388 -$328,047 12,927,442 -1.8% GOODMAN COREY S 14 Oct 2026
Redmile Group, LLC 6.8% -19% $18,474,447 +$9,168,330 9,214,188 +99% Redmile Group, LLC 31 Mar 2026
HBM Healthcare Investments (Cayman) Ltd. 6.5% -24% $17,224,337 +$8,201,837 8,590,692 +91% HBM Healthcare Investments (Cayman) Ltd. 31 Mar 2026
BlackRock, Inc. 5.4% $15,168,650 7,327,850 BlackRock, Inc. 30 Jun 2026
TCG Crossover GP II, LLC 4.2% -57% $13,346,949 -$17,361,014 5,655,487 -57% Chen Yu 30 Jun 2026
TANG CAPITAL PARTNERS LP 6.3% $1,681,410 3,296,883 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024
LSV Associates, LLC 2.2% $4,943,442 2,942,525 Michael A Carusi 27 May 2026
MILLENNIUM MANAGEMENT LLC 1.5% -75% $3,947,290 -$2,381,279 1,988,559 -38% Millennium Management LLC 31 Mar 2026
FMR LLC 3.4% $917,426 1,798,875 FMR LLC 29 Nov 2024
As of 30 Sep 2026, 42 institutional investors reported holding
21.97MFull value: 21,966,797 · shares · 30 Sep 2026
shares of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO). This represents 17% of the company’s total
129.4MFull value: 129,403,824 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
17%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SILVERARC CAPITAL MANAGEMENT, LLC 5.1% 6,565,960 +14% 1.1% $9,126,684
VANGUARD CAPITAL MANAGEMENT LLC 3.7% 4,748,830 -4.5% 0% $6,600,874
MARSHALL WACE, LLP 2.4% 3,148,217 +2.5% 0% $4,376,021
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,408,414 -14% 0% $3,348,553
STATE STREET CORP 1.6% 2,061,974 +38% 0% $2,866,144
VANGUARD PORTFOLIO MANAGEMENT LLC 0.53% 682,614 -8.9% 0% $948,833
VANGUARD FIDUCIARY TRUST CO 0.51% 661,736 -11% 0% $919,813
RENAISSANCE TECHNOLOGIES LLC 0.35% 459,013 -24% 0% $638,028
Empowered Funds, LLC 0.16% 207,475 0% $288,390
Invesco Ltd. 0.12% 153,709 +2.5% 0% $213,655
DEUTSCHE BANK AG\ 0.09% 113,161 +5.3% 0% $157,294
DIMENSIONAL FUND ADVISORS LP 0.07% 95,158 0% $131,835
SECTORAL ASSET MANAGEMENT INC 0.07% 90,000 0.08% $125,100
MORGAN STANLEY 0.06% 80,621 -49% 0% $112,064
AMERICAN CENTURY COMPANIES INC 0.05% 68,212 +218% 0% $94,815
Spark Investment Management LLC 0.03% 38,200 0.08% $53,098
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.03% 38,090 +0.21% 0% $44,946
AXQ CAPITAL, LP 0.03% 33,927 -16% 0.01% $47,159
BNP PARIBAS FINANCIAL MARKETS 0.02% 31,955 0% $44,417
Police & Firemen's Retirement System of New Jersey 0.02% 31,822 0% 0% $44,233
MANUFACTURERS LIFE INSURANCE COMPANY, THE 0.02% 28,698 -7.4% 0% $39,890
Vanguard Global Advisers, LLC 0.02% 28,066 -35% 0% $39,012
HC Advisors, LLC 0.02% 22,900 0% 0.02% $31,831
Callan Family Office, LLC 0.02% 22,419 0% 0% $31,162
EntryPoint Capital, LLC 0.02% 19,613 0.01% $27,262

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
25
Headline period
Q3 2026
Rows shown
1-25 of 25
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 21,966,797 $30,525,839 -$6,847,055 $1.39 42
2026 Q2 105,187,916 $217,870,738 +$23,003,878 $2.07 93
2026 Q1 94,268,933 $189,013,299 +$125,379,513 $2.00 69
2025 Q4 29,193,302 $33,447,411 +$624,566 $1.13 55
2025 Q3 27,785,299 $51,273,440 +$2,395,861 $1.83 60
2025 Q2 29,030,607 $12,060,366 -$2,784,536 $0.42 58
2025 Q1 34,764,459 $21,657,278 -$4,297,920 $0.62 83
2024 Q4 41,028,903 $68,515,761 -$8,509,648 $1.67 85
2024 Q3 45,458,855 $83,126,108 -$40,248,836 $1.82 90
2024 Q2 48,509,608 $292,389,850 -$2,826,841 $6.03 107
2024 Q1 45,776,694 $510,423,087 -$5,822,832 $11.15 105
2023 Q4 45,764,823 $681,456,826 +$185,269,081 $14.89 93
2023 Q3 33,283,050 $159,762,120 -$6,348,070 $4.80 75
2023 Q2 34,283,564 $257,462,824 -$6,376,897 $7.51 74
2023 Q1 35,697,467 $161,353,578 -$6,004,481 $4.52 85
2022 Q4 36,433,730 $410,607,954 -$2,049,707 $11.27 85
2022 Q3 36,439,308 $348,724,761 +$5,422,376 $9.57 96
2022 Q2 35,930,829 $290,675,201 -$16,579,357 $8.09 92
2022 Q1 36,794,716 $621,886,079 +$2,845,527 $16.90 94
2021 Q4 36,290,670 $779,906,251 -$55,903,331 $21.49 103
2021 Q3 34,508,619 $2,548,791,083 +$109,794,972 $73.86 113
2021 Q2 33,314,685 $1,821,610,718 -$28,517,807 $54.68 102
2021 Q1 33,493,682 $2,466,083,905 +$80,496,245 $73.74 90
2020 Q4 32,294,048 $2,779,048,270 +$439,356,967 $86.20 89
2020 Q3 27,250,196 $1,027,708,220 +$1,027,708,220 $37.74 56
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .